← FDA Drug Approvals (Drugs@FDA)

FLEQSUVY

NDA · New Drug Application · Sponsor: AZURITY · Approved 2022-02-04

Drug application

FDA Application #

NDA215602

Application type

New Drug Application

Brand name

FLEQSUVY

Generic name

BACLOFEN

Active ingredients

BACLOFEN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Wilshire Pharmaceuticals, Inc.

First approval

2022-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown